[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349963-105":59,"doc-detail-349963-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-gfpt2o-glcnacylationc-myc-axis-promotes-bladder-cancer-progression-research-open-access","The GFPT2/O-GlcNAcylation/c-Myc axis promotes bladder cancer progression - Research Open Access","","Glucose metabolic reprogramming is a hallmark of bladder cancer, yet the linkage between glucose metabolism and disease onset and progression remains insufficiently defined. To clarify this relationship, the study combines a metabolic gene interaction perturbation network with machine learning to identify GFPT2 as a metabolic prognostic gene, followed by external validation using clinical cohort survival analysis. GFPT2 expression is evaluated by RT-qPCR, Western blotting, and immunohistochemistry, and its pro-tumor roles are tested through cell and animal experiments. Interactions among c-Myc, OGT, and GFPT2 are examined using coimmunoprecipitation and immunofluorescence.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-gfpt2o-glcnacylationc-myc-axis-promotes-bladder-cancer-progression-research-open-access/349963/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-gfpt2o-glcnacylationc-myc-axis-promotes-bladder-cancer-progression-research-open-access/349963.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address about bladder cancer metabolism?","Question",{"text":113,"@type":114},"It examines how glucose metabolic reprogramming relates to the onset and progression of bladder cancer, focusing on the connection between glucose metabolism and disease development.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is GFPT2 identified and validated in this research?",{"text":118,"@type":114},"GFPT2 is identified by integrating a metabolic gene interaction perturbation network with machine learning, then validated externally using survival analysis from clinical cohort data.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism does the study propose for GFPT2’s effect on bladder cancer progression?",{"text":122,"@type":114},"GFPT2 promotes proliferation and migration by regulating the O-GlcNAcylation of c-Myc, inhibiting ubiquitination-mediated degradation, and thereby enhancing c-Myc stability.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349963,1790224900,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Xie etal. Journal of Translational Medicine (2026) 24:347  \n[https://doi.org/10.1186/s12967-026-07811-0](https://doi.org/10.1186/s12967-026-07811-0)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nThe GFPT2/O-GlcNAcylation/c-Myc axis promotes bladder cancer progression  \nHuadong Xie1,2,3†, Tianling Liao4†, Han Tang4, Chengjie Ban4, Zhi Cheng3,4, Kangji Liao4, Yongpeng Li4, Wei Wei5,6,7*, Liquan Zhou3* and Xianlin Yi1,3,4,6,7*  \nAbstract  \nBackground Glucose metabolic reprogramming is a hallmark of bladder cancer. However, the exact relationship between glucose metabolism and the onset and progression of bladder cancer remains poorly understood. Methods We integrated a metabolic gene interaction perturbation network with machine learning algorithms to identify GFPT2 as a metabolic prognostic gene in bladder cancer. External validation was performed through survival analysis using clinical cohort data. GFPT2 expression levels was assessed by RT‒qPCR, Western blotting, and immunohistochemistry. To further explore the protumorigenic role of GFPT2, cell function experiments and animal studies were conducted. Coimmunoprecipitation and immunofluorescence techniques were used to investigate the interactions between the key downstream molecules, c-Myc and OGT, and GFPT2 .  \nResults GFPT2 expression was higher in bladder cancer tissues than in normal tissues, and high GFPT2 expression was closely associated with poor prognosis in bladder cancer patients. GFPT2 overexpression promoted the proliferation and migration of bladder cancer cells. Mechanistic studies revealed that GFPT2 regulated the  \nO-GlcNAcylation of c-Myc, inhibited its ubiquitination-mediated degradation, and thereby enhanced c-Myc stability, which promoted the proliferation and migration of bladder cancer cells.  \nConclusion This study reveals a novel mechanism involving the GFPT2/O-GlcNAcylation/c-Myc signalling axis in the malignant progression of bladder cancer. These findings provide a theoretical basis for potential new therapeutic strategies targeting bladder cancer.  \nKeywords GFPT2, Bladder cancer, O-GlcNAcylation, c-Myc, Progression  \n†Huadong Xie and Tianling Liao are Co-first author.  \n*Correspondence: Wei Wei [weiwei@gxmu.edu.cn](weiwei@gxmu.edu.cn)[ ](weiwei@gxmu.edu.cn)Liquan Zhou [zlqdr1972@163.com](zlqdr1972@163.com)[ ](zlqdr1972@163.com)Xianlin Yi [yixianlin@gxmu.edu.cn](yixianlin@gxmu.edu.cn)  \n1Department of Urology, Hubei province human sperm bank, Maternal and Child Health Hospital of Hubei province, Tongji medical college, Huazhong University of Science and Technology, Wuhan, Hubei 430070, China  \n2Department of Urology, The Fourth Affiliated Hospital of Guangxi Medical University (Liuzhou Workers’ Hospital), Liuzhou, Guangxi 545005, China  \n3Department of Urology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530007, China  \n4School of Graduates, Guangxi Medical University, Nanning,  \nGuangxi 530021, China  \n5Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530021, China  \n6Guangxi Key Laboratory of Extremely Weak Magnetic Field in Cancer Medicine, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530221, China  \n7Guangxi Clinical Research Center for Bladder Cancer, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530221, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the a","cbCaisqeowHdbjql","https://ap.wps.com/l/cbCaisqeowHdbjql","pdf",8532256,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Epidemiology and clinical burden\n## Metabolic reprogramming and glucose pathways","[{\"question\":\"What problem does the study address about bladder cancer metabolism?\",\"answer\":\"It examines how glucose metabolic reprogramming relates to the onset and progression of bladder cancer, focusing on the connection between glucose metabolism and disease development.\"},{\"question\":\"How is GFPT2 identified and validated in this research?\",\"answer\":\"GFPT2 is identified by integrating a metabolic gene interaction perturbation network with machine learning, then validated externally using survival analysis from clinical cohort data.\"},{\"question\":\"What mechanism does the study propose for GFPT2’s effect on bladder cancer progression?\",\"answer\":\"GFPT2 promotes proliferation and migration by regulating the O-GlcNAcylation of c-Myc, inhibiting ubiquitination-mediated degradation, and thereby enhancing c-Myc stability.\"}]","The GFPT2/O-GlcNAcylation/c-Myc axis promotes bladder cancer progression - Research Open Access | PDF",1790086492,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d5a9690e2de48eeeba3682f832ecf55.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01e21a68853456b49c6cd90706e2d1e5.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b41607893f1879bde7d42a083bde79a3.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d50194f14b8b7cae33243d062ae3a113.webp",980,1306]